Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Healthy overweight/obese individuals will be screened for insulin resistance. Both insulin resistant individuals and insulin sensitive individuals (to serve as controls) will be eligible to enroll. Fat cel biopsy and CT scan of the abdomen is required at baseline and after an intervention with either weight loss or pioglitazone (drug to improve insulin resistance). Subjects will repeat insulin resistance test after the intervention as well. Subjects will learn much about their metabolism in this study, and will have an opportunity to improve their insulin resistance.
Age
30–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
nondiabetic defined as fasting plasma glucose \< 126 mg/dL
body mass index 27 to 35 kg/m2
no major organ diseases
able to come to Stanford for regular clinical research center visits
English speaking or has own translator
You may not be if
pregnancy/lactation
history of eating disorder or major psychiatric illness
allergy to thiazolidinedione
elevation of liver enzymes (\> 2.5 times upper normal limit)
Clareo Health | Integrating the Genetic and Metabolic Faces of Obesity
